Clinical Trial Update: Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating safety and efficacy of olopatadine hydrochloride nasal spray in children aged 6-11 with Seasonal Allergic Rhinitis has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Patanase (olopatadine)

Snippet

Sponsor: Alcon Research | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2010-02-09